Welcome to another episode of VJ Oncology! In this episode, we delve into pioneering CAR-T strategies for head and neck cancers and brain tumors, as discussed at the recent iwCAR-T workshop in Miami, Florida.

Join Kedar Khartani from Moffitt Cancer Center and Susanna Baumeister from Dana-Farber Cancer Institute as they explore groundbreaking CAR-T approaches and clinical trials targeting glioblastoma and neuroblastoma. They address the challenges and future prospects of commercializing these therapies, particularly for rare and pediatric cancers.

Discover the exciting developments in ALK-targeting CAR-T cells for neuroblastoma and new antigen-selected TIL therapies for head and neck cancers. This episode offers valuable insights into the evolving landscape of cell therapy in oncology.

Don’t miss this informative discussion! Subscribe and leave a review on your favorite podcast app. Follow us on Twitter at VJ Oncology and visit vjoncology.com for more content from the iwCAR-T workshop.